Data from the pivotal COMET clinical trials reveal how the first topical ocular neuromodulator approved for DED—TRYPTYR (acoltremon ophthalmic solution) 0.003%—delivers a rapid and lasting increase…

In this video, Eric Papas, PhD, presents “Dry eye disease in diabetic neuropathy and its management with Systane Hydration.”

In this video, Jason R. Chin, OD, FAAO, presents “Comparison of Olopatadine Hydrochloride Ophthalmic Solution 0.7% and Loratadine in Preventing Signs and Symptoms of Allergic Conjunctivitis.”